Table 2.
Shows the patients’ kidney function and the progress regarding changes in AKI stages during the study period of 90 days
| AKI stages | |||||
|---|---|---|---|---|---|
| Stage 11 | Stage 21 | Stage 31 | Total | P value | |
| Kidney function | |||||
| Baseline Scr, mean (SD) | 90 (16) | 78 (30) | 68 (17) | 77 (16) | < 0.001 |
| Index Scr, mean (SD) | 160 (17) | 180 (30) | 302 (185) | 219 128) | < 0.001 |
| Maximal IPC Scr, mean (SD) | 160 (18) | 185 (36) | 341 (203) | 235 (148) | < 0.001 |
| Discharge Scr, mean (SD) | 117 (27) | 123 (44) | 178 (143) | 143 (98) | < 0.001 |
| 30-days Scr, mean (SD) | 122 (50) | 118 (80) | 142 (125) | 128 (89) | 0.001 |
| 90-days Scr, mean (SD) | 126 | 114 (74) | 120 (97) | 118 (68) | 0.30 |
| Kidney function within 90 days | |||||
| AKI stage 02, n (%) | 61 (22) | 100 (22) | 72 (20) | 233 (22) | < 0.001 |
| AKI stage 12, n (%) | 53 (19) | 117 (26) | 79 (22) | 249 (23) | |
| AKI stage 22, n (%) | 6 (2) | 29 (6) | 21 (6) | 56 (5) | |
| AKI stage 32, n (%) | 2 (1) | 3 (1) | 20 (6) | 25 (2) | |
| Missing value, n (%) | 153 (40) | 197 (29) | 163 (27) | 513 (31) | |